Status:
COMPLETED
Xinju Xiaogao Prescription Study on Overweight
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborating Sponsors:
China-Japan Friendship Hospital
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Conditions:
Overweight
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Xinju Xiaogao prescription and 10% of it in the treatment of adiposity (stagnation of QI causing phlegm retention)clinical study
Detailed Description
Charged by the three research centers in line with traditional Chinese medicine stagnation of QI causing phlegm retention 120 cases have diabetes were randomly divided into Chinese herbal compound Xin...
Eligibility Criteria
Inclusion
- Aged 18-60 years old
- BMI≥28kg/m2，but\<40kg/m2
- Waistline≥85cm（male）,≥80cm（female）
- Pathoglycemia must fulfill one of those four condition:
- IGT,7.8≤2hPG≤11.0mmol/,
- diabetics take medicine used to treat type 2 diabetes more than 3 month,and 5.6≤FBG≤12.2,and weight change under 4kg.
- stagnation of QI causing phlegm retention
- To sign informed consent.
Exclusion
- After 3-6 months simply controlling their diet and more exercise treatment, body weight weight loss ≥ 5%.
- TG\>4.5mmol/L.
- Suffering from congenital heart disease, rheumatic heart disease, kidney disease, serious active liver disease, peptic ulcer disease or malabsorption syndrome.
- There is a history of pancreatitis or endocrine diseases other than diabetes, diabetes treated with insulin.
- Not suffered myocardial infarction in Past 3 months or unstable angina were confirmed.
- Had been diagnosed as "post-surgical adhesions" .
- There is a history of appetite or abuse of laxatives
- Diastolic blood pressure,uncontrolled or controlled, three times greater than 105mmHg .
- Pregnancy, prepare to pregnant or lactating women prepare.
- Allergies to Chinese medicine , allergic.
- Recurrent gallstone or a history of kidney stones.
- Mentally ill.
- Cancer patients.
- A history of gastrointestinal surgery to lose weight.
- Receiving other clinical studies nearly 3 months.
- Alcohol and / or psychoactive substances, drug abusers and addicts.
- Taking other weight-reducing aid Close within one month
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01142076
Start Date
June 1 2010
End Date
March 1 2011
Last Update
December 11 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.